Literature DB >> 33403441

[Cardio-oncology: radiation dose to the heart during thoracic radiotherapy].

Marciana-Nona Duma1, Andrea Wittig2.   

Abstract

Entities:  

Year:  2021        PMID： 33403441      PMCID： PMC7892504          DOI： 10.1007/s00066-020-01733-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  10 in total

1.  Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.

Authors:  Nikhil Yegya-Raman; Kyle Wang; Sinae Kim; Meral Reyhan; Matthew P Deek; Mutlay Sayan; Diana Li; Malini Patel; Jyoti Malhotra; Joseph Aisner; Lawrence B Marks; Salma K Jabbour
Journal:  J Thorac Oncol       Date:  2018-06-05       Impact factor: 15.609

Review 2.  Cardiac side effects of conventional and particle radiotherapy in cancer patients.

Authors:  A Wittig; R Engenhart-Cabillic
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

3.  Deaths: Final Data for 2015.

Authors:  Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek; Sally C Curtin; Elizabeth Arias
Journal:  Natl Vital Stat Rep       Date:  2017-11

4.  Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

Authors:  Katelyn M Atkins; Bhupendra Rawal; Tafadzwa L Chaunzwa; Nayan Lamba; Danielle S Bitterman; Christopher L Williams; David E Kozono; Elizabeth H Baldini; Aileen B Chen; Paul L Nguyen; Anthony V D'Amico; Anju Nohria; Udo Hoffmann; Hugo J W L Aerts; Raymond H Mak
Journal:  J Am Coll Cardiol       Date:  2019-06-18       Impact factor: 24.094

5.  Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Saro H Armenian; Christina Lacchetti; Ana Barac; Joseph Carver; Louis S Constine; Neelima Denduluri; Susan Dent; Pamela S Douglas; Jean-Bernard Durand; Michael Ewer; Carol Fabian; Melissa Hudson; Mariell Jessup; Lee W Jones; Bonnie Ky; Erica L Mayer; Javid Moslehi; Kevin Oeffinger; Katharine Ray; Kathryn Ruddy; Daniel Lenihan
Journal:  J Clin Oncol       Date:  2016-12-05       Impact factor: 44.544

6.  Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Authors:  Jeffrey D Bradley; Rebecca Paulus; Ritsuko Komaki; Gregory Masters; George Blumenschein; Steven Schild; Jeffrey Bogart; Chen Hu; Kenneth Forster; Anthony Magliocco; Vivek Kavadi; Yolanda I Garces; Samir Narayan; Puneeth Iyengar; Cliff Robinson; Raymond B Wynn; Christopher Koprowski; Joanne Meng; Jonathan Beitler; Rakesh Gaur; Walter Curran; Hak Choy
Journal:  Lancet Oncol       Date:  2015-01-16       Impact factor: 41.316

Review 7.  Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.

Authors:  Sean A Virani; Susan Dent; Christine Brezden-Masley; Brian Clarke; Margot K Davis; Davinder S Jassal; Christopher Johnson; Julie Lemieux; Ian Paterson; Igal A Sebag; Christine Simmons; Jeffrey Sulpher; Kishore Thain; Paaldinesh Thavendiranathan; Jason R Wentzell; Nola Wurtele; Marc André Côté; Nowell M Fine; Haissam Haddad; Bradley D Hayley; Sean Hopkins; Anil A Joy; Daniel Rayson; Ellamae Stadnick; Lynn Straatman
Journal:  Can J Cardiol       Date:  2016-04-07       Impact factor: 5.223

8.  Cardiac Monitoring for Thoracic Radiation Therapy: Survey of Practice Patterns in the United States.

Authors:  Neha P Amin; Nina Desai; Samuel M Kim; Manuj Agarwal; Nivee P Amin
Journal:  Am J Clin Oncol       Date:  2020-04       Impact factor: 2.339

9.  Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.

Authors:  Kyle Wang; Michael J Eblan; Allison M Deal; Matthew Lipner; Timothy M Zagar; Yue Wang; Panayiotis Mavroidis; Carrie B Lee; Brian C Jensen; Julian G Rosenman; Mark A Socinski; Thomas E Stinchcombe; Lawrence B Marks
Journal:  J Clin Oncol       Date:  2017-01-23       Impact factor: 50.717

10.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors:  Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter
Journal:  Eur Heart J       Date:  2016-08-26       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.